当前位置:首页 - 行情中心 - 东诚药业(002675) - 财务分析

东诚药业

(002675)

  

流通市值:110.62亿  总市值:122.70亿
流通股本:7.43亿   总股本:8.25亿

东诚药业(002675)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润1.25亿元,每股收益0.18元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益544543.01万元,未分配利润148788.49万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产928535.69万元,负债383992.68万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入2,043,088,592.831,383,711,882.86686,928,164.922,868,936,537.72
营业总成本1,862,700,437.321,268,737,113.89637,737,923.532,649,051,861.74
其他经营收益
营业利润182,448,575.03113,615,043.1935,290,573.83220,805,997.72
利润总额181,665,295.6112,088,452.6434,851,354.91219,102,842.98
净利润124,555,089.7870,039,313.717,149,804.6141,425,009.68
每股收益
其他综合收益-1,998,026.561,813,407.68-2,717,138.259,642,842.77
综合收益总额122,557,063.2271,852,721.3814,432,666.35151,067,852.45
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计2,878,878,277.842,647,358,901.92,474,529,699.312,567,648,523.38
非流动资产:
非流动资产合计6,406,478,615.436,308,154,947.636,212,449,891.096,067,029,473.06
资产总计9,285,356,893.278,955,513,849.538,686,979,590.48,634,677,996.44
流动负债:
流动负债合计1,686,474,175.841,607,074,426.451,542,348,228.081,753,956,120.72
非流动负债:
非流动负债合计2,153,452,623.161,893,070,205.721,744,750,445.951,509,253,920.83
负债合计3,839,926,7993,500,144,632.173,287,098,674.033,263,210,041.55
所有者权益(或股东权益):
归属于母公司股东权益合计4,373,160,161.174,487,629,570.584,495,424,498.544,480,444,647.93
股东权益合计5,445,430,094.275,455,369,217.365,399,880,916.375,371,467,954.89
负债和股东权益合计9,285,356,893.278,955,513,849.538,686,979,590.48,634,677,996.44
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计2,202,991,434.511,492,531,673.66705,666,851.083,030,867,132.79
经营活动现金流出小计1,861,997,106.941,224,925,398.61591,630,360.782,743,716,353.26
经营活动产生的现金流量净额340,994,327.57267,606,275.05114,036,490.3287,150,779.53
投资活动产生的现金流量:
投资活动现金流入小计897,898,457.79529,090,730.07244,977,797.84831,269,738.37
投资活动现金流出小计1,248,820,265.77831,893,464.33322,159,730.921,546,268,174.7
投资活动产生的现金流量净额-350,921,807.98-302,802,734.26-77,181,933.08-714,998,436.33
筹资活动产生的现金流量:
筹资活动现金流入小计914,557,566.61632,959,214.02202,894,352.411,576,694,563.06
筹资活动现金流出小计685,673,135.37629,162,421.71308,240,759.921,033,113,417.48
筹资活动产生的现金流量净额228,884,431.243,796,792.31-105,346,407.51543,581,145.58
汇率变动对现金及现金等价物的影响2,482,833.66,625,400.823,590,080.2712,148,894.68
现金及现金等价物净增加额221,439,784.43-24,774,266.08-64,901,770.02127,882,383.46
期末现金及现金等价物余额957,060,349.51710,846,299670,718,795.06735,620,565.08
补充资料:
现金及现金等价物的净增加额--24,774,266.08-127,882,383.46
最新报告期:2025-10-30
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
平安证券叶寅,韩盟盟0.270.360.472025-10-30
TOP↑